UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry

The lancet oncology, 2014-12, Vol.15 (13), p.e625-e634

2014

Volltextzugriff (PDF)

Adjuvant tamoxifen adherence in men with early‐stage breast cancer

Cancer, 2022-01, Vol.128 (1), p.59-64

2022

Volltextzugriff (PDF)

Survival in older women with early stage breast cancer receiving low‐dose bisphosphonates or denosumab

Cancer, 2020-09, Vol.126 (17), p.3929-3938

2020

Volltextzugriff (PDF)

Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population‐based study

Cancer, 2022-09, Vol.128 (17), p.3243-3253

2022

Volltextzugriff (PDF)

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1300-1309

2018

Volltextzugriff (PDF)

Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ

Cancer, 2017-03, Vol.123 (6), p.940-947

2017

Volltextzugriff (PDF)

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

Cancer, 2018-03, Vol.124 (5), p.899-906

2018

Volltextzugriff (PDF)

Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms

Cancer, 2020-08, Vol.126 (15), p.3456-3463

2020

Volltextzugriff (PDF)

Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer

Cancer, 2018-12, Vol.124 (24), p.4685-4691

2018

Volltextzugriff (PDF)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

Cancer medicine (Malden, MA), 2020-10, Vol.9 (19), p.6961-6971

2020

Volltextzugriff (PDF)

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials

Cancer, 2018-04, Vol.124 (8), p.1760-1769

2018

Volltextzugriff (PDF)

Best of the year: Advanced breast cancer in 2023

Breast (Edinburgh), 2024-04, Vol.74, p.103677-103677, Article 103677

2024

Volltextzugriff (PDF)

Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment

Cancer medicine (Malden, MA), 2023-09, Vol.12 (17), p.17740-17752

2023

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Volltextzugriff (PDF)

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System

The oncologist (Dayton, Ohio), 2017-11, Vol.22 (11), p.1292-1300

2017

Volltextzugriff (PDF)

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Breast cancer research : BCR, 2019-07, Vol.21 (1), p.78-78, Article 78

2019

Volltextzugriff (PDF)

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4222-4228

2013

Volltextzugriff (PDF)

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Journal of clinical oncology, 2018-08, Vol.36 (23), p.2433-2443

2018

Volltextzugriff (PDF)

Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer

The oncologist (Dayton, Ohio), 2020-11, Vol.25 (11), p.937-942

2020

Volltextzugriff (PDF)

Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

The oncologist (Dayton, Ohio), 2020-09, Vol.25 (9), p.749-757

2020

Volltextzugriff (PDF)

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2645-2652

2011

Volltextzugriff (PDF)

Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy

The oncologist (Dayton, Ohio), 2019-03, Vol.24 (3), p.313-318

2019

Volltextzugriff (PDF)

Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (3), p.553-564

2014

Volltextzugriff (PDF)

Male Breast Cancer According to Tumor Subtype and Race: A Population-Based Study

Cancer, 2013-05, Vol.119 (9), p.1611-1617

2013

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(35)
Cancer
(27)
Annals Of Surgical Oncology
(23)
Cancer Research
(14)
Breast Cancer Research And Treatment
(8)
Gaceta Mexicana De Oncolog A
(8)
Jama Oncology
(8)
The Oncologist
(8)
The oncologist
(8)
Annals Of Surgery
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry

Adjuvant tamoxifen adherence in men with early‐stage breast cancer

Survival in older women with early stage breast cancer receiving low‐dose bisphosphonates or denosumab

Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population‐based study

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms

Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials

Best of the year: Advanced breast cancer in 2023

Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer

Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy

Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

Male Breast Cancer According to Tumor Subtype and Race: A Population-Based Study

Suchergebnisse filtern